2018
Corrigendum to 'Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux' [The International Journal of Antimicrobial Agents 50/1 (2017) 55-62].
Matt U,
Selchow P,
Molin MD,
Strommer S,
Sharif O,
Schilcher K,
Andreoni F,
Stenzinger A,
Zinkernagel AS,
Zeitlinger M,
Sander P,
Nemeth J.
Int J Antimicrob Agents. 2018 Jan;51(1):122. doi: 10.1016/j.ijantimicag.2017.10.012. Epub 2017 Nov 14.
2018
Heme and hemolysis in innate immunity: adding insult to injury.
Martins R,
Knapp S.
Curr Opin Immunol. 2018 Feb;50:14-20. doi: 10.1016/j.coi.2017.10.005. Epub 2017 Nov 5. Review.
2018
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis.
Göschl L,
Preglej T,
Hamminger P,
Bonelli M,
Andersen L,
Boucheron N,
Gülich AF,
Müller L,
Saferding V,
Mufazalov IA,
Hirahara K,
Seiser C,
Matthias P,
Penz T,
Schuster M,
Bock C,
Waisman A,
Steiner G,
Ellmeier W.
J Autoimmun. 2018 Jan;86:51-61. doi: 10.1016/j.jaut.2017.09.008. Epub 2017 Sep 28.
2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha,
Jessica Ebner,
Johannes Schmöllerl,
Mareike Roth,
Thomas Eder,
Adrián César-Razquin,
Alexey Stukalov,
Sarah Vittori,
Matthias Muhar,
Bin Lu,
Martin Aichinger,
Julian Jude,
André C Müller,
Balázs Győrffy,
Christopher R Vakoc,
Peter Valent,
Keiryn L Bennett,
Johannes Zuber,
Giulio Superti-Furga,
Florian Grebien.
Nat Commun. 2018 May 18;9(1):1983. doi: 10.1038/s41467-018-04329-y.
2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer,
Barbara Maurer,
Elizabeth C Heyes,
Abbarna A Cumaraswamy,
Angelika Berger-Becvar,
Elvin D de Araujo,
Anna Orlova,
Patricia Freund,
Frank Ruge,
Jisung Park,
Gary Tin,
Siawash Ahmar,
Charles-Hugues Lardeau,
Irina Sadovnik,
Dávid Bajusz,
György Miklós Keserű,
Florian Grebien,
Stefan Kubicek,
Peter Valent,
Patrick T Gunning,
Richard Moriggl.
Leukemia. 2018 May;32(5):1135-1146. doi: 10.1038/s41375-017-0005-9. Epub 2018 Feb 2.
2017
Interactome-based approaches to human disease.
M Caldera*,
P Buphamalai*,
F Müller,
J Menche.
Current Opinions in Systems Biology 3:88; 2017.
2017
Integrating personalized gene expression profiles into predictive disease-associated gene pool.
J Menche*,
E Guney*,
A.
npj Systems Biology & Applications 3:10; 2017. doi:10.1038/s41540-017-0009-0
2017
Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein.
Khamina K ,
Lercher A ,
Caldera M,
Schliehe C ,
Vilagos B ,
Sahin M,
Kosack L,
Bhattacharya A,
Májek P,
Stukalov A,
Sacco R,
James LC,
Pinschewer DD,
Bennett KL,
Menche J,
Bergthaler A.
PLoS Pathogens 13(12): e1006758; 2017.
2017
First in human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
Boidol B,
Kornauth C,
van der Kouwe E,
Prutsch N,
Kazianka L,
Gültekin S,
Hoermann G,
Mayerhoefer ME,
Hopfinger G,
Hauswirth A,
Panny M,
Aretin MB,
Hilgarth B,
Sperr WR,
Valent P,
Simonitsch-Klupp I,
Moriggl R,
Merkel O,
Kenner L,
Jäger U,
Kubicek S,
Staber PB.
Blood. 2017 Sep 27. pii: blood-2017-05-785683. doi: 10.1182/blood-2017-05-785683. [Epub ahead of print]
2017
The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis.
Kosack L,
Gawish R,
Lercher A,
Vilagos B,
Hladik A,
Lakovits K,
Bhattacharya A,
Schliehe C,
Mesteri I,
Knapp S,
Bergthaler A.
Sci Rep. 2017 Sep 12;7(1):11289. doi: 10.1038/s41598-017-10637-y.
